Cargando…

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value

Alzheimer's disease (AD) is an age-associated neurodegenerative disease characterized by the progressive loss of cognitive function, loss of memory and insomnia, and abnormal behavioral signs and symptoms. Among the various theories that have been put forth to explain the pathophysiology of AD,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srinivasan, Venkatramanujam, Kaur, Charanjit, Pandi-Perumal, Seithikurippu, Brown, Gregory M., Cardinali, Daniel P.
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004402/ https://www.ncbi.nlm.nih.gov/pubmed/21197086 http://dx.doi.org/10.4061/2011/741974

Ejemplares similares

Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
por: Pandi-Perumal, Seithikurippu R., et al.
Publicado: (2011)

Melatonin in Mitochondrial Dysfunction and Related Disorders
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2011)

Possible Application of Melatonin in Long COVID
por: Cardinali, Daniel P., et al.
Publicado: (2022)

Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
por: Cardinali, Daniel P., et al.
Publicado: (2020)

Melatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights
por: Cardinali, Daniel P, et al.
Publicado: (2022)

Autism Spectrum Disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin
por: Brown, Gregory M., et al.
Publicado: (2021)

Melatonin in Alzheimer's disease and other neurodegenerative disorders
por: Srinivasan, V, et al.
Publicado: (2006)

Melatonin as an Add-On Treatment of COVID-19 Infection: Current Status
por: Brown, Gregory M., et al.
Publicado: (2021)

Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration
por: Cardinali, Daniel P., et al.
Publicado: (2020)

The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014)

Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury
por: Wu, Xiao-li, et al.
Publicado: (2020)

Melatonin in Antinociception: Its Therapeutic Applications
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2012)

Melatonin, immune function and aging
por: Srinivasan, V, et al.
Publicado: (2005)

Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2
por: Yadalam, Pradeep Kumar, et al.
Publicado: (2022)

Melatonin, Clock Genes, and Mammalian Reproduction: What Is the Link?
por: Brzezinski, Amnon, et al.
Publicado: (2021)

Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi, Taro, et al.
Publicado: (2019)

Relationship Between Melatonin and Cardiovascular Disease
por: Ozkalayci, Flora, et al.
Publicado: (2021)

The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species
por: Stroethoff, Martin, et al.
Publicado: (2020)

Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial*
por: Nishikimi, Mitsuaki, et al.
Publicado: (2018)

The Melatonin Agonist Ramelteon Induces Duration-Dependent Clock Gene Expression through cAMP Signaling in Pancreatic INS-1 β-Cells
por: Nishiyama, Keiji, et al.
Publicado: (2014)

Ramelteon, as a Melatonin Agonist, is Expected to be Effective on COVID-19 Induced Organ Damage: The Hypothetic Role of NF-κB Signaling Pathway
por: Mehdipoor, Mahdis, et al.
Publicado: (2022)

The influence of intermittent fasting on the circadian pattern of melatonin while controlling for caloric intake, energy expenditure, light exposure, and sleep schedules: A preliminary report
por: Almeneessier, Aljohara S., et al.
Publicado: (2017)

An Assessment of Melatonin’s Therapeutic Value in the Hypoxic-Ischemic Encephalopathy of the Newborn
por: Cardinali, Daniel P.
Publicado: (2019)

Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
por: Marupuru, Srujitha, et al.
Publicado: (2022)

Measurement of melatonin in body fluids: Standards, protocols and procedures
por: de Almeida, Eduardo Alves, et al.
Publicado: (2010)

Book Review: The Sleep Solution: Secrets for a Good Night’s Sleep
por: Pandi-Perumal, Seithikurippu R.
Publicado: (2017)

Pharmacology of Ramelteon, a Selective MT(1)/MT(2) Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders
por: Miyamoto, Masaomi
Publicado: (2009)

Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010)

Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients
por: Zaki, Nevin FW, et al.
Publicado: (2020)

Melatonin or Ramelteon for Delirium Prevention in the Intensive Care Unit: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Aiello, Giuseppe, et al.
Publicado: (2023)

Are Type 2 Diabetes Mellitus and Depression Part of a Common Clock Genes Network?
por: Karthikeyan, Ramanujam, et al.
Publicado: (2018)

A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008)

COVID-Somnia: How the Pandemic Affects Sleep/Wake Regulation and How to Deal with it?
por: Gupta, Ravi, et al.
Publicado: (2020)

SARS-CoV-2 Infection: Paving Way for Sleep Disorders in Long Term!
por: Gupta, Ravi, et al.
Publicado: (2021)

Smart, Personalized Sleep: The Benefits and Risks of Artificial Intelligence and Wearables in the Consumer Sleep Technology Market
por: Jahrami, Haitham, et al.
Publicado: (2023)

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
por: Karthikeyan, Ramanujam, et al.
Publicado: (2014)

Sleep in space as a new medical frontier: the challenge of preserving normal sleep in the abnormal environment of space missions
por: Pandi-Perumal, Seithikurippu R., et al.
Publicado: (2016)

Melatonin Therapy in Patients with Alzheimer’s Disease
por: Cardinali, Daniel P., et al.
Publicado: (2014)

Cerebral Epiphyseal Proteins and Melatonin Modulate the Hepatic and Renal Antioxidant Defense of Rats
por: Bharti, Vijay K., et al.
Publicado: (2011)

Clinical Aspects of Melatonin Intervention in Alzheimer’s Disease Progression
por: Cardinali, Daniel P, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pljqjr8sft7sg2j93bni4h8kcv